Skip to main content

Sten H. Vermund and Patricia J. Kissinger highlight the growing energy consumption of artificial intelligence technologies as an emerging risk to public health. They emphasize the need to recognize this impact and propose actionable solutions to mitigate AI's strain on vital health resources.

Addressing AI's Increasing Energy Demand: A Public Health Concern

In this edition of STAT Health Tech, discover how a biotech startup transformed the disappointment of a failed clinical trial into a breakthrough AI model, alongside other industry insights.

From Setback to Smart Solution: How a Biotech Startup Created an AI Model from a Failed Trial

Which of the emerging obesity drugs has the potential to truly lead the market? Which company recently made headlines with a record-breaking IPO? And what decisions might the Food and Drug Administration be making about these treatments?

Exploring Breakthroughs in Obesity Medications and the Rise of Peptide Therapies

Wearable devices generate vast amounts of health data, but until now, this information has largely remained outside clinical settings. Recent advancements by companies like Oura and Whoop are starting to bridge this gap, potentially integrating wearable-generated health data into clinical practice for better patient monitoring and outcomes.

Wearable Health Devices Are Poised to Enter Clinical Care with New Data Innovations

Although the number of prescription drug shortages in the U.S. decreased by 23% last year, a recent analysis highlights ongoing systemic problems affecting the availability of many medicines.

Analysis Reveals Persistent Systemic Issues in U.S. Prescription Drug Shortages Despite Recent Decline

William Padula highlights a critical gap in healthcare: while cures exist, the real challenge lies in establishing systems to finance and effectively deliver these expensive treatments.

Financing Models Needed for Multi-Million Dollar Gene Therapy Treatments

Despite the headline-negative results of Grail’s multi-cancer early detection trial, an experienced oncologist reveals important lessons beyond the initial outcome. This pioneering randomized trial provides key insights into the future potential and challenges of cancer screening technologies. The oncologist highlights three critical takeaways from the study, emphasizing that the broader implications extend past the trial’s primary results, offering hope for advancements in early cancer detection and improved patient care.

Insights from the First Randomized Trial of Multi-Cancer Early Detection: An Oncologist’s Perspective

Ambient scribes, the pioneering AI application in healthcare, are now being developed to assist patients by efficiently taking notes during doctor visits. This technology aims to enhance medical documentation accuracy and streamline the consultation process from the patient’s perspective.

Introducing AI-Powered Ambient Scribes for Patient Use in Doctor’s Offices

Darshak Sanghavi highlights a growing concern: the financial consequences of healthcare are increasingly impacting patient care itself, creating a complex web where billing practices directly influence clinical outcomes.

Opinion: Navigating the AI Battle in Medical Billing Between Providers and Insurers

In this edition of STAT's AI Prognosis, Brittany Trang explores the pope's recent encyclical on artificial intelligence, highlighting key insights and their significance for Catholic hospitals and the wider health care industry.

Understanding the Pope’s Encyclical on AI: Implications for Catholic Hospitals and the Broader Healthcare Sector